Choose the object.
Then the path.
Then the terms.
MZN partnership is not an all-or-nothing portfolio transaction. A counterparty can engage a strategic program, a single asset, a technical cluster, or the OPU review case. Integration with HUAI or Zoyan is optional unless the selected partnership specifically requires it.
Mazzaneh, GPU Sentinel, Tokenizer, LLM systems, HUAI, Zoyan and OPU can each attract different counterparties.
There is more than one way to enter MZN.
The first decision is what the counterparty is actually trying to advance—not whether they are prepared to take on the entire portfolio.
Mazzaneh Re-Launch
Country entry, local operations, merchants, payments/comms, marketplace activation and selected Phase 1 modules.
Market-entry route → Product programZoyan
Human-facing Phase 3 productization, privacy/consent, interface, pilot, distribution and strategic integration.
Zoyan route → Intelligence programHUAI
Cross-phase human-context intelligence architecture: implementation, research, validation, safety and selected integration.
HUAI route → Asset / clusterStandalone Technical Assets
GPU Sentinel, Tokenizer, LLM Anatomy/Framework/Optimization, ZOE/ISBP, BioCode/HDTP and other selected families.
Asset routes → Institutional / reviewOne-Person Unicorn
Independent provenance and substance review, challenge, publication, institutional evaluation and category development.
OPU route → Portfolio discoveryNot sure yet?
Start from the portfolio map, identify the smallest strategically meaningful object, then define the appropriate Phase 3 path.
Open Portfolio →The same asset can support different deal types.
After choosing the object, define what the counterparty actually wants to accomplish.
Market / Operating Partner
Local launch, distribution, market access, commercial operations, ecosystem relationships.
Technical / Specialist Partner
Benchmarking, reproduction, security review, implementation hardening or pilot validation.
License / OEM / Strategic
License, OEM, integration, transfer, product partnership or other asset-specific structures.
Lab / Institution
Research collaboration, protocol evaluation, human-centered AI work or specialist review.
Investment / JV
Program-specific or object-specific capital without assuming acquisition or control of the rest of MZN.
OPU / Category Review
Independent evaluation and challenge. This is not a product transaction and does not extend Phase 2 solo formation.
Scope before signatures.
The relationship should be designed around the evidence object and objective rather than forcing a generic “strategic partnership” label.
Program, asset, cluster or review case.
Operate, validate, pilot, license, research, invest or evaluate.
Public, controlled, restricted/NDA or independent review as required.
Standalone, cluster, HUAI, Zoyan or broader convergence—only if useful.
Rights, background IP, geography, exclusivity, milestones, economics and governance.
Bounded implementation with explicit success/failure criteria.
Expand, license, invest, merge, hold or stop based on results.
A relationship in one object does not silently absorb the rest of MZN.
Integration is a negotiated option, not the price of entry.
Advance one product or asset without HUAI/Zoyan dependency.
Connect only the capabilities needed for the selected program or pilot.
Explore Mazzaneh + selected Phase 2 assets + HUAI + Zoyan where the strategic case supports it.
Partnership does not depend on festival attendance.
International events can create introductions and visibility, but any Phase 3 route can begin directly with the relevant partner, institution, lab, investor, operator or evaluator.